PM

Pannala Mahipal Reddy

Active Director Director DIN 08519892
DIN 08519892 First appointment Jul 2019 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2019
Shareholding value •••• Premium profile

About Pannala Mahipal Reddy

Data last updated:

Pannala Mahipal Reddy is a Director at Libramed Pharmaceuticals Private Limited (since 2019). The company operates in Pharma. Libramed Pharmaceuticals Private Limited reported revenue of ₹4.63 Cr (FY 2025).

DIN 08519892
Primary Designation Director
Industry Pharma
First Appointment 26 Jul 2019
Oldest Company Age 7 yrs
Largest company Libramed Pharmaceuticals Private Limited · ₹4.63 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director26 Jul 20192019₹4.63 Cr (FY 2025)Active

Directorship timeline

Open interactive timeline →
Libramed Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Pannala Mahipal Reddy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pannala Mahipal Reddy

Pannala Mahipal Reddy currently holds 1 directorship: Libramed Pharmaceuticals Private Limited (Director, since 26 Jul 2019, revenue ₹4.63 Cr (FY 2025)).

Pannala Mahipal Reddy was first appointed on 26 Jul 2019 as Director at Libramed Pharmaceuticals Private Limited.

The current boards of Pannala Mahipal Reddy's companies include Balakrishna Dyavanapelly (Libramed Pharmaceuticals Private Limited), Bharath Gajula (Libramed Pharmaceuticals Private Limited), Latha Sri Bura (Libramed Pharmaceuticals Private Limited), Mahendhar Punnam (Libramed Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available